Author:
Hodgson Darren R.,Dougherty Brian A.,Lai Zhongwu,Fielding Anitra,Grinsted Lynda,Spencer Stuart,O’Connor Mark J.,Ho Tony W.,Robertson Jane D.,Lanchbury Jerry S.,Timms Kirsten M.,Gutin Alexander,Orr Maria,Jones Helen,Gilks Blake,Womack Chris,Gourley Charlie,Ledermann Jonathan,Barrett J. Carl
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Pommier, Y., O’Connor, M. J. & de Bono, J. Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action. Sci. Transl. Med. 8, 362ps17 (2016).
2. Roy, R., Chun, J. & Powell, S. N. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat. Rev. Cancer 12, 68–78 (2011).
3. Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917–921 (2005).
4. O’Connor, M. J. et al. Generating preclinical models to assess bone marrow toxicity induced by the PARP inhibitor olaparib in combination with chemotherapy. Cancer Res. 73, 4420 (2013).
5. McCabe, N. et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res. 66, 8109–8115 (2006).
Cited by
193 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献